Despite the poor prognosis of patients with renal carcinoma and pulmonary metastases instances of prolonged survival with regression of the lung lesions have been reported. We present one such case, in which multiple cannon ball lesions seen on the chest radiograph resolved completely for nine years and a prolonged clinical remission was achieved after hormone treatment and chemotherapy. lesions. Two months after treatment the patient began complaining of a non-productive cough and a further chest radiograph (fig 1) showed multiple "cannon balir lesions 2-4 cm in diameter characteristic of metastatic renal cell carcinoma. Hormone treatment with medroxyprogesterone acetate 200 mg intramuscularly five times a week and chemotherapy with vinblastine 0-1 mg/kg intravenously once a week was administered. Over the following four months the patient reported subjective improvement and regression of the tumor nodules on the chest radiograph was noted. In the sixth month of treatment there was a complete disappearance of all pulmonary lesions (fig 2) and the patient felt well.
Despite the poor prognosis of patients with renal carcinoma and pulmonary metastases instances of prolonged survival with regression of the lung lesions have been reported. We present one such case, in which multiple cannon ball lesions seen on the chest radiograph resolved completely for nine years and a prolonged clinical remission was achieved after hormone treatment Of greater interest is the possible relationship between the length of treatment and the duration of the full remission. Owing to the excellent initial response it was decided to continue with combined treatment for a prolonged period. Such an approach has precedents in other metastatic illnesses, most notably breast cancer, in which treatment may be continued for as long as it appears to be effective. When after four years the patient was still in remission, it was decided to discontinue chemotherapy to avoid cumulative bone marrow and neurological toxicity and to continue with hormone treatment alone. Altogether the patient received treatment for eight years, during which time she was in full remission. Her quality of life was good, with only mild hair loss and some bone marrow suppression.
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The disease recurred within one year of the termination of treatment, suggesting that it had been controlled by the treatment and, more specifically, by the hormone therapy. It should, however, be noted that assessment of any treatment in renal carcinoma is complicated by the peculiar tendency of this disease to remain dormant for many years or to regress spontaneously without treatment. In one study of patients with prolonged survival after nephrectomy, 11 % developed metastatic lesions after 10 years.4 Cases documenting spontaneous tumour regression have likewise been reported.5 The most common site in both these instances has been the lungs, so that spontaneous regression with late recurrence cannot be completely excluded in the present case. 
